Yaning He

575 total citations
16 papers, 423 citations indexed

About

Yaning He is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Yaning He has authored 16 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Molecular Biology and 7 papers in Cancer Research. Recurrent topics in Yaning He's work include HER2/EGFR in Cancer Research (4 papers), BRCA gene mutations in cancer (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Yaning He is often cited by papers focused on HER2/EGFR in Cancer Research (4 papers), BRCA gene mutations in cancer (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Yaning He collaborates with scholars based in China. Yaning He's co-authors include Yingbo Shao, Xianfu Sun, Chaojun Liu, Hui Liu, Qi Chen, Xuhui Guo, Hengwei Zhang, Hui Liu, Yang Yu and Hui Liu and has published in prestigious journals such as PLoS ONE, Medicine and Annals of Surgical Oncology.

In The Last Decade

Yaning He

16 papers receiving 418 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yaning He China	10	214	208	153	82	47	16	423
Catherine J. Kennedy Australia	13	194 0.9×	234 1.1×	119 0.8×	176 2.1×	44 0.9×	25	560
Marcell A. Szász Hungary	10	148 0.7×	210 1.0×	128 0.8×	73 0.9×	29 0.6×	16	534
Jolanta Szade Poland	12	266 1.2×	143 0.7×	151 1.0×	78 1.0×	24 0.5×	32	406
Mai Tomiguchi Japan	12	146 0.7×	280 1.3×	272 1.8×	80 1.0×	37 0.8×	24	490
Fumitake Kai Japan	10	231 1.1×	220 1.1×	100 0.7×	117 1.4×	33 0.7×	19	436
Carla Strina Italy	10	242 1.1×	107 0.5×	125 0.8×	71 0.9×	59 1.3×	25	362
Kristopher A. Lofgren United States	9	198 0.9×	278 1.3×	88 0.6×	77 0.9×	26 0.6×	20	451
Kerstin Unterschemmann Germany	6	171 0.8×	220 1.1×	205 1.3×	95 1.2×	81 1.7×	8	485
Fernando Ortiz-Martínez Spain	9	220 1.0×	221 1.1×	120 0.8×	77 0.9×	78 1.7×	12	419
Zhanhuai Wang China	12	243 1.1×	231 1.1×	170 1.1×	68 0.8×	38 0.8×	24	501

Countries citing papers authored by Yaning He

Since Specialization

Citations

This map shows the geographic impact of Yaning He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaning He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaning He more than expected).

Fields of papers citing papers by Yaning He

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yaning He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaning He. The network helps show where Yaning He may publish in the future.

Co-authorship network of co-authors of Yaning He

This figure shows the co-authorship network connecting the top 25 collaborators of Yaning He. A scholar is included among the top collaborators of Yaning He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yaning He. Yaning He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Shao, Yingbo, Huijuan Guan, Yang Yu, et al.. (2023). Clinicopathological characteristics and value of HER2-low expression evolution in breast cancer receiving neoadjuvant chemotherapy. The Breast. 73. 103666–103666. 7 indexed citations

Shao, Yingbo, Yang Yu, Huijuan Guan, et al.. (2022). Clinical, Pathological Complete Response, and Prognosis Characteristics of HER2-Low Breast Cancer in the Neoadjuvant Chemotherapy Setting: A Retrospective Analysis. Annals of Surgical Oncology. 29(13). 8026–8034. 41 indexed citations

Shao, Yingbo, Yang Yu, Yaning He, et al.. (2022). A real-world study of anlotinib as third-line or above therapy in patients with her-2 negative metastatic breast cancer. Frontiers in Oncology. 12. 939343–939343. 6 indexed citations

Shao, Yingbo, Yang Yu, Qi Chen, et al.. (2022). HER2-low expression does not affect the clinical outcomes of metastatic breast cancer treated with CDK4/6 inhibitor: A real-world study. Frontiers in Endocrinology. 13. 1000704–1000704. 13 indexed citations

Yu, Yang, Yaning He, Yingbo Shao, Qi Chen, & Hui Liu. (2020). lncRNA PCNAP1 predicts poor prognosis in breast cancer and promotes cancer metastasis via miR‑340‑5p‑dependent upregulation of SOX4. Oncology Reports. 44(4). 1511–1523. 12 indexed citations

Shao, Yingbo, Yang Yu, Yaning He, Qi Chen, & Hui Liu. (2019). Serum ATX as a novel biomarker for breast cancer. Medicine. 98(13). e14973–e14973. 26 indexed citations

He, Yaning, et al.. (2019). Relationships between SNPs and prognosis of breast cancer and pathogenic mechanism. Molecular Genetics & Genomic Medicine. 7(9). e871–e871. 16 indexed citations

He, Yaning, Hui Liu, Qi Chen, et al.. (2016). Relationship between five GWAS-identified single nucleotide polymorphisms and female breast cancer in the Chinese Han population. Tumor Biology. 37(7). 9739–9744. 12 indexed citations

Shao, Yingbo, Xianfu Sun, Yaning He, Chaojun Liu, & Hui Liu. (2015). Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast Cancer. PLoS ONE. 10(7). e0133830–e0133830. 177 indexed citations

10.

Chen, Qi, Yaning He, Chaojun Liu, et al.. (2015). [Associations between TOX3 rs3803662 polymorphisms and immunological markers of breast cancer].. PubMed. 95(34). 2783–6. 2 indexed citations

11.

Sun, Xianfu, Suxia Luo, Yaning He, et al.. (2014). Screening of the miRNAs related to breast cancer and identification of its target genes.. PubMed. 35(6). 696–700. 13 indexed citations

12.

Zhang, Hengwei, Xianfu Sun, Yaning He, et al.. (2013). Bioinformatics analysis of breast cancer bone metastasis related gene-CXCR4. Asian Pacific Journal of Tropical Medicine. 6(9). 732–738. 4 indexed citations

13.

Yang, Lian‐Yue, Fan Wu, Yiming Tao, et al.. (2013). The Expression of Egfl7 in Human Normal Tissues and Epithelial Tumors. The International Journal of Biological Markers. 28(1). 71–83. 39 indexed citations

14.

Liu, Hui, Hengwei Zhang, Xianfu Sun, et al.. (2013). Tamoxifen-resistant breast cancer cells possess cancer stem-like cell properties. Chinese Medical Journal. 126(16). 3030–3034. 44 indexed citations

15.

Liu, Hui, Hengwei Zhang, Xianfu Sun, et al.. (2013). A Cross-Sectional Study of Associations Between Nonsynonymous Mutations of the BARD1 Gene and Breast Cancer in Han Chinese Women. Asia Pacific Journal of Public Health. 25(4_suppl). 8S–14S. 7 indexed citations

16.

Li, Juntao, Hengwei Zhang, Xuhui Guo, et al.. (2013). [Effects of high glucose on in vitro invasiveness of human breast cancer cell line MDA-MB-435].. PubMed. 93(2). 89–92. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact